Collagenase clostridium histolyticum

DB00048ApprovedInvestigationalProtein Based TherapiesCollagen-specific Enzyme

Collagenase clostridium histolyticum is a collagenase enzyme used to promote debridement of necrotic tissue in burns and skin ulcers as well as to treat Dupuytren's contracture and Peyronie's disease. It is beneficial in the breakdown of collagen plaques for the treatment of Dupuytren's contracture and Peyronie's disease.

Protein structure of Collagenase clostridium histolyticum
Mechanism
Curator reviewed · 8 references
Primary indication
Collagenase clostridium histolyticum is indicated for the treatment of adults with Dupuytren's contracture with a palpable cord.Curator reviewed · 4 structured indications
Formula / weight
C5028H7666N1300O1564S21 · 112023.2 Da
First approval
Canada, 2014 · United States, 2006
Also known as
Clostridiopeptidase A · Clostridium histolyticum enzymes · Collagenase · collagenase clostridium histolyticum-aaes
Code names
AA-4500 · PF-5076985
Brand names
  • Santyl
  • Xiaflex

Resolves to

What you can answer from here — as of July 17, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
100Drug interactionsStructured to mechanism, not free text
Sign in
67Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
16Marketed productsAcross 9 countries and 12 labellers
Sign in
3ATC codesIncluding every combination product, plus 14 drug categories
Sign in
26+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Collagenase clostridium histolyticum, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account